News

Free Webinar in October

Innovative strategies to advance severe TBI treatment
read more

Reducing Complications related to Thromolysis and Thrombectomy

Pilot-study combining recanalization methods with Cerebrolysin® shows strong positive signals
read more
1 … 37 38 39 40 41 … 67
1 … 34
Go to Archive

Congresses

11th European Stroke Organisation Conference

Helsinki, Finland
21 - 23 May 2025
GO TO EVENT

17th World Stroke Congress

Barcelona, Spain
22 - 25 October 2025
GO TO EVENT

Notice to U.S. Visitors

Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.

Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional. For any medical inquiries, please consult with a healthcare professional.